I remember after RVX's ASSURE analysis, many said we RVX could never go to Phase 3.

Well, we're a long way through phase 3 and the FDA has finally recognized the trial.

This NR adds significant value to the program and the company. Many analysts simply ignore studies that are not recognized by the FDA.

bfw